{"blog": [], "keywords": [{"value": "Antibiotics", "name": "subject", "rank": "1", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "2", "is_major": "N"}, {"value": "Bacteria", "name": "subject", "rank": "3", "is_major": "N"}, {"value": "Preventive Medicine", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Livestock Diseases", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Methicillin-Resistant Staphylococcus Aureus", "name": "subject", "rank": "6", "is_major": "N"}, {"value": "E Coli (Bacteria)", "name": "subject", "rank": "7", "is_major": "N"}, {"value": "Epidemics", "name": "subject", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/03/08/upshot/were-losing-the-race-against-antibiotic-resistance-but-theres-also-reason-for-hope.html", "document_type": "article", "byline": {"person": [{"middlename": "E.", "firstname": "Aaron", "role": "reported", "rank": 1, "lastname": "CARROLL", "organization": ""}], "original": "By AARON E. CARROLL"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbWide.jpg", "legacy": {"wide": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-articleLarge.gif", "legacy": {"xlarge": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-articleLarge.gif", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/03/07/upshot/08up-healthantibiotic-illo/08up-healthantibiotic-illo-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "The Upshot", "word_count": "1178", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "Preventing infections through vaccination or public health measures is the outcome to aim for.", "pub_date": "2016-03-08T00:00:00Z", "news_desk": "Business", "headline": {"kicker": "The Upshot", "print_headline": "Antibiotic Resistance Is Worrisome, but Not Hopeless", "main": "We\u2019re Losing the Race Against Antibiotic Resistance, but There\u2019s Also Reason for Hope", "content_kicker": "The New Health Care"}, "print_page": "3", "snippet": "Preventing infections through vaccination or public health measures is the outcome to aim for.", "_id": "56dd6b2b38f0d874be467d01", "slideshow_credits": null, "abstract": "The Upshot; growing resistance to antibiotics could be countered with development of new ones, but relatively low profits for drug companies have slowed innovation; several programs to incentivize new antibiotic drug development, including money for research, discussed."}